ArticleSeminars in arthritis and rheumatism2023

Rituximab is associated with worse COVID-19 outcomes in patients with rheumatoid arthritis: A retrospective, nationally sampled cohort study from the U.S. National COVID Cohort Collaborative (N3C).

Namrata Singh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.